|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/19 | |
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 35/04 | |||
| A61K 49/04 | |||
| A61K 49/08 |
| (11) | Number of the document | 2509618 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10793288.1 |
| Date of filing the European patent application | 2010-12-08 | |
| (97) | Date of publication of the European application | 2012-10-17 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2010/052048 |
| Date | 2010-12-08 |
| (87) | Number | WO 2011/070358 |
| Date | 2011-06-16 |
| (30) | Number | Date | Country code |
| 0921525 | 2009-12-08 | GB |
| (72) |
ANTHONY, Daniel, GB
SIBSON, Nicola, GB
SEYMOUR, Len, GB
FISHER, Kerry, GB
|
| (73) |
Oxford University Innovation Limited,
Buxton Court 3 West Way, Botley Oxford OX2 0JB,
GB
|
| (54) | Systemic administration of an agent that permeabilises tumour vasculature |
| Systemic administration of an agent that permeabilises tumour vasculature |